Cipla
Trish Knight serves as the Vice President and Head of Sales & Market Access at Cipla Therapeutics, bringing extensive experience in the pharmaceutical industry. Previously, Trish held the position of Zone Vice President at Amarin Pharma Inc. and contributed significantly at Sanofi in several roles, including Zone Vice President for US Sales focusing on Diabetes and Cardiovascular, and Associate Vice President leading the Regional Account Management Team and the Pharmacy Account Team. Trish Knight earned a Bachelor of Arts in Humanities from Rosemont College.
This person is not in the org chart
This person is not in any offices
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.